Get started
Author

Valerio Guarente

Observed name: V Guarente
ORCID: 0000-0002-2001-8000
Observed ORCID: 0000-0002-2001-8000
OpenAlex ID: A5068316536
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
2021 · Paolo Sportoletti, Filomena De Falco, et al. · International Journal of Molecular Sciences · 30
PDF
Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib
2021 · Francesca Romana Mauro, Diana Giannarelli, et al. · Cancers · 27
PDF
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY
2023 · Thomas Chatzikonstantinou, Lydia Scarfò, et al. · EClinicalMedicine · 24
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations
2019 · Paolo Sportoletti, Letizia Celani, et al. · Leukemia · 20
PDF
Lessons, Challenges and Future Therapeutic Opportunities for PI3K Inhibition in CLL
2021 · Valerio Guarente, Paolo Sportoletti · Cancers · 19
PDF
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice
2020 · Paolo Sportoletti, Daniele Sorcini, et al. · Leukemia · 19
PDF
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status
2021 · Stefano Baldoni, Beatrice Del Papa, et al. · Frontiers in Oncology · 13
PDF
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor model
2022 · Stefano Molica, Diana Giannarelli, et al. · American Journal of Hematology · 10
PDF
Immune correlates of protection by vaccine against SARS‐CoV ‐2 in patients with chronic lymphocytic leukaemia
2022 · Daniele Sorcini, Filomena De Falco, et al. · British Journal of Haematology · 5
Role of Age, Fitness and Concomitant Medications in CLL Patients Treated with Venetoclax
2020 · Anna Maria Frustaci, Annalisa Biagi, et al. · Blood · 5
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL
2024 · Thomas Chatzikonstantinou, Lydia Scarfò, et al. · HemaSphere · 4
PDF
TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B‐Cell Lymphoma in the Real‐Life Patient Journey
2026 · Lisa Argnani, Cinzia Pellegrini, et al. · Hematological Oncology · 2
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia
2021 · Valerio Guarente, Giovanni Martino, et al. · Frontiers in Oncology · 2
PDF
Richter's transformation in the heart
2021 · Andrea Marra, Francesco Adamo, et al. · The Lancet Oncology · 2
Real-World Evidence on Therapeutic Strategies and Treatment-Sequencing in Patients with Chronic Lymphocytic Leukemia: An International Study of Eric, the European Research Initiative on CLL
2021 · Thomas Chatzikonstantinou, Lydia Scarfo, et al. · Blood · 1
The Amyloidosis You Don’t Expect!
2026 · A Polo, V Guarente, et al. · European Heart Journal Supplements
PDF
Survival Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Treated in the Chemoimmunotherapy Vs BTK Inhibitor (BTKi) Eras: A European Research Initiative on CLL (ERIC) Study
2024 · T C, Eva Minga, et al. · Blood
S149: Other Malignancies in the History of Cll: the Final Analysis of the International Multicenter Study Conducted by Eric, in Harmony.
2023 · Thomas Chatzikonstantinou, Lydia Scarfò, et al. · HemaSphere
Works count: 18
Citation count: 183
H-index: 8
I10-index: 8
Year
Topic
Type